Compare MSN & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSN | CURX |
|---|---|---|
| Founded | 1948 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.8M |
| IPO Year | 1995 | 2024 |
| Metric | MSN | CURX |
|---|---|---|
| Price | $0.31 | $5.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 93.3K | 21.4K |
| Earning Date | 11-13-2026 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.09 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $77,829,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.30 | $0.21 |
| 52 Week High | $0.55 | $13.44 |
| Indicator | MSN | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 28.04 | 64.84 |
| Support Level | N/A | $3.79 |
| Resistance Level | $0.39 | $6.00 |
| Average True Range (ATR) | 0.02 | 0.45 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 14.15 | 98.57 |
Emerson Radio Corp designs, sources, imports, markets, sells and licenses to certain licensees a variety of houseware and consumer electronic products, both domestically and internationally, under the Emerson brand name. The Company's core business consists of selling, distributing, and licensing various low and moderately priced houseware and consumer electronic products in various categories. Its products are Houseware Products consist Microwave Ovens, Compact Refrigerators, Toaster Ovens, Heaters and Fans; Audio Products consist Clock Radios, Bluetooth Speakers, Karaoke Machines, Wireless Charging; and Other consist Televisions, Security Products, Massagers. It operates in One segment. Majority of revenue comes from United States.
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.